Meningitis | eHealth News | Page 5

The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent serogroup B meningococcal disease among people aged 10 through 25.

FDA Approves New Meningococcal Disease Vaccine

HealthDay.com - Jan 26, 2015 0

Bexsero is the second vaccine approved in the past three months to prevent this disease

1...3 45Page 5 of 5

Archives